TransMedics Group TMDX Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Edges Lower Fulcrum Therapeutics FULC Q1 2026 Earnings NarrowerthanExpected Loss Despite Mild Stock Dip PARR Q1 2026 Earnings Earnings Miss Weighs on Results but Stock Edges Higher NXE Q1 2026 Earnings Wider Than Expected Loss as Development Continues PMTW Q1 2026 Earnings Significant EPS Miss as Trust Reports 016 vs 038 Estimate AYTU Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Stock Rises Slightly